07:00 , Aug 2, 2010 |  BC Week In Review  |  Company News

Axela, Xceed Molecular Corp. deal

Axela acquired Xceed Molecular for an undisclosed sum. Axela gains Xceed's Ziplex System for gene-expression analysis, Breast Cancer Prognostic Assay and Colon Cancer Xpress Chip. The company expects to submit a 510(k) to FDA in...
07:00 , Apr 26, 2010 |  BC Week In Review  |  Company News

Axela, Salomao and Zoppi deal

Axela, Salomao and innovations management firm Cria Opportunities Inc. (Richmond, B.C.) signed a memorandum of understanding to form a JV to manufacture and commercialize Axela's products in Brazil and South America. The JV, which will...
07:00 , Jun 1, 2009 |  BC Week In Review  |  Company News

Axela, Proteome Sciences, University of Geneva deal

Axela will use its multiplex dotLab technology to develop blood-based assays of Proteome Sciences' and the university's biomarkers to detect disorders related to brain damage. Axela's technology measures protein levels and characterizes protein interactions. Axela...
07:00 , Aug 18, 2008 |  BC Week In Review  |  Company News

Axela Biosensors Inc., Johns Hopkins University deal

The parties will collaborate to develop a diagnostic to determine treatment options for acute myocardial infarction (AMI) patients. Axela will provide its dotLab technology to detect troponin complex levels, and the university will use serum...
07:00 , Apr 28, 2008 |  BC Week In Review  |  Company News

Axela Biosensors Inc. board of directors update

Axela Biosensors Inc. , Toronto, Ontario   Business: Microfluidics, Supply/Service   Appointed: Michael Treble, president of Isis Pharmaceuticals Inc. 's Ibis BioSciences Inc. subsidiary, as chairman  ...
07:00 , Apr 7, 2008 |  BC Week In Review  |  Company News

Axela Biosensors Inc. board of directors update

Axela Biosensors Inc. , Toronto, Ontario   Business: Microfluidics, Supply/Service   Appointed: Bill Clarke, CEO of Cellectar Inc. ; David Giddings, president and CEO of Digilab Inc.; and Dave Lemus, CFO of MorphoSys AG  ...
07:00 , May 14, 2007 |  BC Week In Review  |  Company News

Axela Biosensors Inc., BioCheck Inc. sales and marketing update

Axela received non-exclusive rights to sell BioCheck's reagents for research and diagnostic applications. Axela plans to market the reagents as disposable assays to be run on Axela's dotLab multiplex sensor system, which measures protein levels...
07:00 , Oct 2, 2006 |  BC Week In Review  |  Company News

Abnova Corp., Axela Biosensors Inc. deal

Axela and Abnova will co-develop biomarker panels for use on Axela's dotLab protein binding detection system. Abnova will generate antibodies against undisclosed targets selected by Axela. Axela will sell any biomarker panels developed, and Abnova...
07:00 , Jul 10, 2006 |  BC Week In Review  |  Company News

Axela Biosensors Inc. management update

Axela Biosensors Inc. , Toronto, Ontario   Business: Microfluidics   Hired: Paul Smith as VP of sales and marketing, formerly VP of sales for Europe and North America at Ciphergen Biosystems Inc.  ...
08:00 , Jan 16, 2006 |  BC Week In Review  |  Company News

Axela Biosensors Inc., Kimberly-Clark deal

KMB granted Axela exclusive rights to IP covering diffraction-based biosensors and immunodiagnostics. Axela said the IP complements its Diffractive Optics Technology, which uses microfluidics and photonics to detect the interactions between molecules and targets. KMB...